Efavirenz-based therapies associated with better outcomes in HIV-infected adults
Wednesday, October 15, 2008 - 07:21
in Health & Medicine
A study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that HIV-infected patients taking the antiretroviral drug efavirenz were more likely to adhere to treatment and less likely to experience virologic failure and death compared to patients taking nevirapine...
Read the whole article on Science Centric
More from Science Centric
Related
- Efavirenz-based initial therapies associated with better outcomes in HIV-infected adultsTue, 14 Oct 2008, 14:29:00 EDT
- Certain HIV treatment less effective when used with anti-TB therapySun, 3 Aug 2008, 14:35:24 EDT
- Integrating antiretroviral therapy with TB treatment for co-infections reduces mortalityThu, 16 Oct 2008, 11:29:22 EDT
- Hepatitis C infection: treatment options equally effective, likelihood of success known early onWed, 22 Jul 2009, 17:52:00 EDT
- Consumer electronics can help improve patient healthTue, 27 Oct 2009, 11:51:32 EDT